Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
17.32
-0.06 (-0.35%)
At close: Nov 28, 2025, 1:00 PM EST
17.14
-0.18 (-1.01%)
After-hours: Nov 28, 2025, 4:42 PM EST
Xencor Market Cap
Xencor has a market cap or net worth of $1.24 billion as of November 28, 2025. Its market cap has decreased by -25.46% in one year.
Market Cap
1.24B
Enterprise Value
721.03M
1-Year Change
-25.46%
Ranking
Category
Stock Price
$17.32
Market Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $1.24B, an increase of 404.01%. That is a compound annual growth rate of 14.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 1.24B | -23.09% |
| Dec 31, 2024 | 1.61B | 24.44% |
| Dec 29, 2023 | 1.29B | -17.18% |
| Dec 30, 2022 | 1.56B | -33.50% |
| Dec 31, 2021 | 2.35B | -6.40% |
| Dec 31, 2020 | 2.51B | 28.51% |
| Dec 31, 2019 | 1.95B | -4.07% |
| Dec 31, 2018 | 2.03B | 97.53% |
| Dec 29, 2017 | 1.03B | -4.93% |
| Dec 30, 2016 | 1.08B | 82.97% |
| Dec 31, 2015 | 591.80M | 17.51% |
| Dec 31, 2014 | 503.60M | 87.28% |
| Dec 31, 2013 | 268.90M | 9.58% |
| Dec 3, 2013 | 245.40M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |